{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:33:12Z","timestamp":1788381192299,"version":"build-2803163510"},"reference-count":53,"publisher":"The Endocrine Society","issue":"2","funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Disorders","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Ectopic ACTH syndrome (EAS), in which Cushing syndrome is caused by excessive ACTH secretion from a tumor located outside of the pituitary, is associated with an impaired quality of life and an increased mortality rate. Outcomes can be improved with successful tumor localization and resection, which often proves difficult. In order to distinguish EAS from Cushing disease, a significantly more common condition where excessive ACTH is secreted from a pituitary tumor, bilateral inferior petrosal sinus sampling (IPSS) is often necessary. Correct performance and interpretation of IPSS hence becomes crucial to avoid inappropriate future interventions, including surgical procedures. Once an ectopic source of ACTH is confirmed biochemically, identifying the causative tumor is often challenging since they can be located in unexpected areas and potentially be very small. Additionally, EAS carries a risk of severe hypercortisolism, which sometimes needs urgent treatment to avoid disastrous outcomes. The cases here illustrate pitfalls in diagnostic biochemical testing, describe helpful imaging strategies to improve the chances of tumor detection, and review available options to rapidly normalize severe hypercortisolism in critical situations.<\/jats:p>","DOI":"10.1210\/jendso\/bvae194","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T07:38:11Z","timestamp":1738568291000},"source":"Crossref","is-referenced-by-count":19,"title":["Recognition and Management of Ectopic ACTH Secreting Tumors"],"prefix":"10.1210","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6876-9762","authenticated-orcid":false,"given":"Henrik","family":"Elenius","sequence":"first","affiliation":[{"name":"Diabetes and Endocrinology and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Disorders, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0534-8025","authenticated-orcid":false,"given":"Lynnette K","family":"Nieman","sequence":"additional","affiliation":[{"name":"Diabetes and Endocrinology and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Disorders, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"issue":"2","key":"2025020307380414600_bvae194-B1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ecl.2018.01.005","article-title":"The ectopic adrenocorticotropic hormone syndrome: rarely easy, always challenging","volume":"47","author":"Hayes","year":"2018","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"9996","key":"2025020307380414600_bvae194-B2","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing's syndrome","volume":"386","author":"Lacroix","year":"2015","journal-title":"Lancet"},{"issue":"2","key":"2025020307380414600_bvae194-B3","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1210\/jc.2005-1542","article-title":"The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up","volume":"91","author":"Isidori","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025020307380414600_bvae194-B4","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/cen.14008","article-title":"The clinical impact of [(68) Ga]-DOTATATE PET\/CT for the diagnosis and management of ectopic adrenocorticotropic hormone\u2014secreting tumours","volume":"91","author":"Wannachalee","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2025020307380414600_bvae194-B5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1530\/EC-20-0089","article-title":"The role of 68Ga-DOTA derivatives PET-CT in patients with ectopic ACTH syndrome","volume":"9","author":"Ceccato","year":"2020","journal-title":"Endocr Connect"},{"issue":"2","key":"2025020307380414600_bvae194-B6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1530\/EC-16-0010","article-title":"Comparison of 68Ga-DOTANOC PET\/CT and contrast-enhanced CT in localisation of tumours in ectopic ACTH syndrome","volume":"5","author":"Goroshi","year":"2016","journal-title":"Endocr Connect"},{"issue":"4","key":"2025020307380414600_bvae194-B7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1530\/EJE-16-0809","article-title":"Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: a multicenter study","volume":"176","author":"Davi","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"2025020307380414600_bvae194-B8","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.arcmed.2006.05.015","article-title":"Ectopic ACTH-secreting syndrome: a single center experience report with a high prevalence of occult tumor","volume":"37","author":"Hernandez","year":"2006","journal-title":"Arch Med Res"},{"issue":"8","key":"2025020307380414600_bvae194-B9","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1210\/jc.2004-2527","article-title":"Cushing's syndrome due to ectopic corticotropin secretion: twenty years' experience at the National Institutes of Health","volume":"90","author":"Ilias","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025020307380414600_bvae194-B10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1530\/EJE-15-0968","article-title":"Prevalence and clinical features of the ectopic ACTH syndrome in patients with gastroenteropancreatic and thoracic neuroendocrine tumors","volume":"174","author":"Kamp","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2025020307380414600_bvae194-B11","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1210\/jcem.84.4.5576","article-title":"Lack of utility of (111)In-pentetreotide scintigraphy in localizing ectopic ACTH producing tumors: follow-up of 18 patients","volume":"84","author":"Torpy","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025020307380414600_bvae194-B12","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/s12020-019-02098-2","article-title":"(68)Ga-DOTATOC PET\/CT in detecting neuroendocrine tumours responsible for initial or recurrent paraneoplastic Cushing's syndrome","volume":"67","author":"Belissant Benesty","year":"2020","journal-title":"Endocrine"},{"issue":"2","key":"2025020307380414600_bvae194-B13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11154-010-9139-z","article-title":"The ectopic ACTH syndrome","volume":"11","author":"Alexandraki","year":"2010","journal-title":"Rev Endocr Metab Disord"},{"key":"2025020307380414600_bvae194-B14","first-page":"283","article-title":"Clinical and laboratory studies of ectopic humoral syndromes","volume":"25","author":"Liddle","year":"1969","journal-title":"Recent Prog Horm Res"},{"issue":"5","key":"2025020307380414600_bvae194-B15","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/1097-0142(197505)35:5<1430::AID-CNCR2820350529>3.0.CO;2-O","article-title":"Studies on ectopic ACTH-producing tumors. II. Clinical and biochemical features of 30 cases","volume":"35","author":"Imura","year":"1975","journal-title":"Cancer"},{"issue":"8","key":"2025020307380414600_bvae194-B16","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1590\/S0004-27302007000800007","article-title":"Ectopic ACTH syndrome","volume":"51","author":"Isidori","year":"2007","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"5","key":"2025020307380414600_bvae194-B17","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's syndrome: an endocrine society clinical practice guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2025020307380414600_bvae194-B18","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing's disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"2025020307380414600_bvae194-B19","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1210\/jc.2003-030871","article-title":"Diagnosis and complications of Cushing's syndrome: a consensus statement","volume":"88","author":"Arnaldi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025020307380414600_bvae194-B20","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.1210\/clinem\/dgad454","article-title":"Ovine CRH stimulation and 8\u2005mg dexamethasone suppression tests in 323 patients with ACTH-dependent Cushing's syndrome","volume":"109","author":"Elenius","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"2025020307380414600_bvae194-B21"},{"issue":"7","key":"2025020307380414600_bvae194-B22","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1507\/endocrj.EJ20-0837","article-title":"The usefulness of the combined high-dose dexamethasone suppression test and desmopressin stimulation test in establishing the source of ACTH secretion in ACTH-dependent Cushing's syndrome","volume":"68","author":"Qiao","year":"2021","journal-title":"Endocr J"},{"issue":"1","key":"2025020307380414600_bvae194-B23","first-page":"176","article-title":"A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome","volume":"82","author":"Newell-Price","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"1-2","key":"2025020307380414600_bvae194-B24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.20452\/pamw.65","article-title":"[The desmopressin test in the diagnosis of Cushing's disease]","volume":"117","author":"Gasiniska","year":"2007","journal-title":"Pol Arch Med Wewn"},{"issue":"10","key":"2025020307380414600_bvae194-B25","first-page":"3569","article-title":"The desmopressin test in the differential diagnosis between Cushing's disease and pseudo-Cushing states","volume":"85","author":"Moro","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2025020307380414600_bvae194-B26","doi-asserted-by":"crossref","first-page":"e4295","DOI":"10.1210\/clinem\/dgac533","article-title":"Is desmopressin useful in the evaluation of Cushing syndrome?","volume":"107","author":"Castinetti","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025020307380414600_bvae194-B27","doi-asserted-by":"crossref","first-page":"R201","DOI":"10.1530\/EJE-18-0007","article-title":"DIAGNOSIS OF ENDOCRINE DISEASE: the role of the desmopressin test in the diagnosis and follow-up of Cushing's syndrome","volume":"178","author":"Vassiliadi","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2025020307380414600_bvae194-B28","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s11102-016-0729-y","article-title":"Second-line tests in the differential diagnosis of ACTH-dependent Cushing's syndrome","volume":"19","author":"Barbot","year":"2016","journal-title":"Pituitary"},{"issue":"5","key":"2025020307380414600_bvae194-B29","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s11154-022-09723-y","article-title":"Diagnostic accuracy of bilateral inferior petrosal sinus sampling using desmopressin or corticotropic- releasing hormone in ACTH-dependent Cushing's syndrome: a systematic review and meta-analysis","volume":"23","author":"Valizadeh","year":"2022","journal-title":"Rev Endocr Metab Disord"},{"issue":"4","key":"2025020307380414600_bvae194-B30","doi-asserted-by":"crossref","first-page":"e1673","DOI":"10.1210\/clinem\/dgz194","article-title":"The optimal cut-off of BIPSS in differential diagnosis of ACTH-dependent Cushing's syndrome: is stimulation necessary?","volume":"105","author":"Chen","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2025020307380414600_bvae194-B31","doi-asserted-by":"crossref","first-page":"dgaa409","DOI":"10.1210\/clinem\/dgaa409","article-title":"Non-invasive diagnostic strategy in ACTH-dependent Cushing's syndrome","volume":"105","author":"Frete","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2025020307380414600_bvae194-B32","doi-asserted-by":"crossref","first-page":"6005","DOI":"10.1210\/jc.2004-1378","article-title":"Identification of patients with Cushing's disease with negative pituitary adrenocorticotropin gradients during inferior petrosal sinus sampling: prolactin as an index of pituitary venous effluent","volume":"89","author":"Findling","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2025020307380414600_bvae194-B33","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S2213-8587(23)00150-X","article-title":"Diagnostic challenges in cyclic Cushing's syndrome: a systematic review","volume":"11","author":"Nowak","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"2025020307380414600_bvae194-B34","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1210\/jc.2009-1146","article-title":"Use of the desmopressin test in the differential diagnosis of pseudo-Cushing state from Cushing's disease","volume":"95","author":"Tirabassi","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025020307380414600_bvae194-B35","doi-asserted-by":"crossref","first-page":"luae088","DOI":"10.1210\/jcemcr\/luae088","article-title":"Prolonged adrenal insufficiency after osilodrostat exposure with eventual recovery of adrenal function","volume":"2","author":"Tejani","year":"2024","journal-title":"JCEM Case Rep"},{"issue":"6","key":"2025020307380414600_bvae194-B36","doi-asserted-by":"crossref","first-page":"K29","DOI":"10.1093\/ejendo\/lvad060","article-title":"Prolonged adrenocortical blockade following discontinuation of Osilodrostat","volume":"188","author":"Poirier","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2025020307380414600_bvae194-B37","doi-asserted-by":"crossref","first-page":"L1","DOI":"10.1093\/ejendo\/lvad167","article-title":"Prolonged adrenal insufficiency following discontinuation of osilodrostat treatment for intense hypercortisolism","volume":"190","author":"Ferriere","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2025020307380414600_bvae194-B38","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1210\/jc.2012-3943","article-title":"The lateralization accuracy of inferior petrosal sinus sampling in 501 patients with Cushing's disease","volume":"98","author":"Wind","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025020307380414600_bvae194-B39","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1210\/jc.2003-031812","article-title":"The role of [(18)F]fluorodeoxyglucose positron emission tomography and [(111)In]-diethylenetriaminepentaacetate-D-Phe-pentetreotide scintigraphy in the localization of ectopic adrenocorticotropin-secreting tumors causing Cushing's syndrome","volume":"89","author":"Pacak","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2025020307380414600_bvae194-B40","doi-asserted-by":"crossref","first-page":"e14769","DOI":"10.1097\/MD.0000000000014769","article-title":"The utility of 18F-FDG and 68Ga-DOTA-peptide PET\/CT in the evaluation of primary pulmonary carcinoid: a systematic review and meta-analysis","volume":"98","author":"Jiang","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"2025020307380414600_bvae194-B41","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1507\/endocrj.K10E-265","article-title":"Clinical features and management of ectopic ACTH syndrome at a single institute in Japan","volume":"57","author":"Doi","year":"2010","journal-title":"Endocr J"},{"issue":"9","key":"2025020307380414600_bvae194-B42","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1007\/s00259-017-3728-y","article-title":"Guideline for PET\/CT imaging of neuroendocrine neoplasms with (68)Ga-DOTA-conjugated somatostatin receptor targeting peptides and (18)F-DOPA","volume":"44","author":"Bozkurt","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"2025020307380414600_bvae194-B43","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1210\/JC.2015-1589","article-title":"Conventional and nuclear medicine imaging in ectopic Cushing's syndrome: a systematic review","volume":"100","author":"Isidori","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025020307380414600_bvae194-B44","doi-asserted-by":"crossref","first-page":"101513","DOI":"10.1016\/j.beem.2021.101513","article-title":"New types of localization methods for adrenocorticotropic hormone-dependent Cushing's syndrome","volume":"35","author":"Senanayake","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"2025020307380414600_bvae194-B45","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1210\/jc.2009-2282","article-title":"Utility of various functional and anatomic imaging modalities for detection of ectopic adrenocorticotropin-secreting tumors","volume":"95","author":"Zemskova","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025020307380414600_bvae194-B46","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1148\/rg.352140164","article-title":"Somatostatin receptor imaging with 68Ga DOTATATE PET\/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation","volume":"35","author":"Hofman","year":"2015","journal-title":"Radiographics"},{"issue":"4","key":"2025020307380414600_bvae194-B47","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1210\/er.2013-1048","article-title":"The treatment of Cushing's disease","volume":"36","author":"Pivonello","year":"2015","journal-title":"Endocr Rev"},{"issue":"1","key":"2025020307380414600_bvae194-B48","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ando.2022.09.020","article-title":"Pneumocystis pneumonia in patients with Cushing's syndrome: a French multicenter retrospective study","volume":"84","author":"Lugat","year":"2023","journal-title":"Ann Endocrinol (Paris)"},{"issue":"8","key":"2025020307380414600_bvae194-B49","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2015-1818","article-title":"Treatment of Cushing's syndrome: an endocrine society clinical practice guideline","volume":"100","author":"Nieman","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025020307380414600_bvae194-B50","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1530\/EJE-14-0913","article-title":"Rapid control of severe neoplastic hypercortisolism with metyrapone and ketoconazole","volume":"172","author":"Corcuff","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2025020307380414600_bvae194-B51","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S2213-8587(18)30155-4","article-title":"Advances in the medical treatment of Cushing's syndrome","volume":"7","author":"Feelders","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2025020307380414600_bvae194-B52","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/clinem\/dgaa778","article-title":"Adrenally directed medical therapies for Cushing syndrome","volume":"106","author":"Tritos","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025020307380414600_bvae194-B53","doi-asserted-by":"crossref","first-page":"L13","DOI":"10.1530\/EJE-21-0147","article-title":"Rapid control of severe ectopic Cushing's syndrome by oral osilodrostat monotherapy","volume":"184","author":"Bessiene","year":"2021","journal-title":"Eur J Endocrinol"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/9\/2\/bvae194\/61738276\/bvae194.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/9\/2\/bvae194\/61738276\/bvae194.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T07:38:25Z","timestamp":1738568305000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvae194\/7997017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,6]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,1,6]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvae194","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2025,1,6]]},"article-number":"bvae194"}}